Bank of America
ACHL

Bank of America’s Achilles Therapeutics ACHL Stock Holding History

Bank of America’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15
Closed -$15 – 8494
2024
Q3 		$15 Buy
+15
New +$12 ﹤0.01% 8006
2024
Q2 		– Sell
-1,092
Closed -$1.36K – 8482
2024
Q1 		$1.36K Sell
1,092
-21,500
-95% -$23.2K ﹤0.01% 7171
2023
Q4 		$20.1K Sell
22,592
-50,650
-69% -$43.4K ﹤0.01% 6784
2023
Q3 		$66.6K Buy
73,242
+63,100
+622% +$60K ﹤0.01% 6406
2023
Q2 		$9.58K Sell
10,142
-5,153
-34% -$4.89K ﹤0.01% 6874
2023
Q1 		$14.6K Buy
15,295
+4,625
+43% +$5.01K ﹤0.01% 6842
2022
Q4 		$9.6K Buy
10,670
+1,114
+12% +$1.88K ﹤0.01% 6926
2022
Q3 		$21K Sell
9,556
-2,763
-22% -$7.82K ﹤0.01% 7017
2022
Q2 		$31K Buy
12,319
+1,869
+18% +$4.61K ﹤0.01% 7041
2022
Q1 		$31K Buy
10,450
+5,922
+131% +$21K ﹤0.01% 7365
2021
Q4 		$23K Buy
4,528
+2,161
+91% +$13.1K ﹤0.01% 7478
2021
Q3 		$18K Sell
2,367
-29,979
-93% -$197K ﹤0.01% 7427
2021
Q2 		$316K Sell
32,346
-543,739
-94% -$7.37M ﹤0.01% 5767
2021
Q1 		$9.54M Buy
+576,085
New +$9.53M ﹤0.01% 2774

Other funds holding ACHL

SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America's ACHL Position: Q4 2024 in Review

Bank of America sold out of Achilles Therapeutics (ACHL) in Q4 2024, closing a stake of 15 shares — an estimated $15 sold.

Bank of America first reported a position in ACHL in Q1 2021 and held it in 14 quarters. The position peaked at $9.54M in Q1 2021. 21 funds tracked by Wall St. Rank hold ACHL as of Q4 2024.

  • Bank of America reported no remaining Achilles Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bank of America sold 15 Achilles Therapeutics shares in Q4 2024, an estimated $15.
  • Bank of America first reported a position in Achilles Therapeutics in Q1 2021 and held it in 14 quarters.
  • Bank of America's Achilles Therapeutics position peaked at $9.54M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Achilles Therapeutics as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.